Search the Newsreel

Bellevue Gold (ASX:BGL) Advances as Gold Stocks Shine

Cenovus Energy Inc (CVE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Cenovus Energy Inc (CVE) by business segment and region, presenting data in USD. For business segments, Crude Oil, Gasoline, and Diesel and Distillate are the largest contributors. Regionally, the United States and Canada account for the …

Vuzix Corporation (0LRL) Q3 2022 Earnings Report - Results, Call & Slides

This article provides the Q3 2022 earnings report for Vuzix Corporation (0LRL), detailing actual EPS of -$0.15 (beating consensus) and actual revenue of $3.43M (beating expectations) with a 13.52% YoY growth. It includes details on the earnings announcement date, conference call, slide deck, and …

Here's Why We Think Vulcan Materials (NYSE:VMC) Is Well Worth Watching

This article suggests that Vulcan Materials (NYSE:VMC) is a company worth watching. It implies that there are positive indicators making it an attractive prospect for investors. The content will likely delve into reasons behind this recommendation.

Is Rising Efficiency And Free Cash Flow Altering The Investment Case For Vulcan Materials (VMC)?

Vulcan Materials (VMC) has demonstrated significant operational improvements over the last five years, including 10.6% annual revenue growth, improved operating leverage, and expanded free cash flow margins. These efficiencies strengthen its investment case by highlighting its ability to generate cash, fund share repurchases, and …

Corvus Pharmaceuticals Inc (CRVS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Corvus Pharmaceuticals Inc (CRVS), including its stock price, market cap, and a note that P/E, P/B, and P/CF data are not yet disclosed by the company. It lists various sections for stock analysis like Financials, Discussions, Analysis, …

Corvus Pharmaceuticals Inc (CRVS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Corvus Pharmaceuticals Inc (CRVS), detailing its support, resistance, and various indicator readings. It covers commonly used technical indicators like MACD, RSI, and moving averages, offering a summary of buy, sell, and neutral signals. The analysis aims to …

VUZI|Vuzix Corp|Price:2.290|Chg%:-0.010

This article provides a company profile for Vuzix Corp (VUZI), detailing its business in AI-powered Smart Glasses and AR technologies. It lists key financials, executive team, and shareholder information, noting that institutional shareholding increased in Q1 2026 and product sales are the largest revenue …

Vulcan Materials stock trades steadily as aggregates demand supports recent earnings

Vulcan Materials stock is performing steadily, driven by strong aggregates demand, which underpinned higher revenue and profit in its latest quarterly report. The company saw increased net income and EPS, benefiting from pricing strategies and operational efficiencies amidst robust infrastructure and construction activity in …

Bank of New York Mellon Corp Boosts Stock Position in Cenovus Energy Inc $CVE

Bank of New York Mellon Corp increased its stake in Cenovus Energy Inc. by 12% in the first quarter, acquiring an additional 165,987 shares and bringing its total holdings to 1,551,366 shares valued at approximately $41.2 million. This comes after Cenovus Energy reported strong …

Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE

Absolute Gestao de Investimentos Ltda. has acquired a new position in Kenvue Inc. (NYSE:KVUE), purchasing 923,260 shares valued at approximately $15.92 million, making it their 16th largest holding. Other institutional investors have also adjusted their stakes, with some increasing their holdings significantly. Kenvue's stock …

ENvue Medical, Inc. Revenue Breakdown – NASDAQ:FEED

Corvus Pharmaceuticals (CRVS) Board Resignation Puts Leadership Outlook In Focus

Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE)

Kenvue recently received FDA approval for Tylenol with Naproxen, a new over-the-counter pain reliever offering up to 12 hours of pain relief and slated for distribution across major U.S. retailers. This product launch adds a differentiated option to Kenvue's Self Care portfolio, potentially strengthening …

Is Kenvue (KVUE) Stock A Bargain With Lawsuits Back In Focus?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Kenvue stock has delivered a decline of 11.7% over the past year, yet the current Discounted Cash Flow (DCF) intrinsic value estimate indicates …

Vuzix Corp (VUZI) Institutional Confidence

Vuzix Corp (VUZI) has an institutional shareholding score of 3.00, ranking 37th in the Electronic Equipment & Parts industry. The institutional shareholding proportion is 42.81%, showing a significant quarter-over-quarter increase of 43.97%. Quanta Computer Inc. is the largest institutional shareholder with 7.69M shares, while …

Vulcan Materials Co (VMC) Income Statement

This article provides the quarterly and annual income statements for Vulcan Materials Co (VMC), detailing financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, income before tax, net income, and earnings per share. It also includes an FAQ section explaining …

Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The FDA's approval of Tylenol with Naproxen, a new over the counter pain reliever offering up to 12 hours of relief, has put Kenvue …

5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC

Kryger Capital LLC has acquired a significant new stake in Kenvue Inc. (NYSE:KVUE), purchasing over 5.2 million shares valued at approximately $89.84 million, making it their sixth-largest holding. Other institutional investors like Healthcare of Ontario Pension Plan Trust Fund and Renaissance Technologies LLC also …

Vulcan Materials Co (VMC) Financial Health: Profitability & Balance Sheet Analysis

Vulcan Materials Co (VMC) currently has a financial score of 6.36, ranking 10 out of 15 in the Construction Materials industry, indicating a weak financial status but average operating efficiency. The company recently reported a 7.42% year-over-year increase in quarterly revenue, reaching $1.76 billion, …

Form DEF 14A ENvue Medical Inc For: 24 July By Investing.com

This article announces the filing of Form DEF 14A by ENvue Medical Inc. for July 24. It appears to be a standard financial news announcement from Investing.com, providing basic information about a regulatory filing. The content itself is very brief and focuses solely on …

Vulcan Materials Co (VMC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Vulcan Materials Co (VMC), highlighting its major shareholders and institutional holdings. Key shareholders include State Farm Insurance Companies and various Vanguard and BlackRock entities. The report also provides a breakdown of shareholder types, institutional holding trends over …

GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE

GABELLI & Co INVESTMENT ADVISERS INC. increased its stake in Kenvue Inc. (NYSE:KVUE) by 77.3% in the first quarter, now owning 742,600 shares valued at $12.8 million. Other institutional investors also modified their holdings, while Kenvue recently declared a quarterly dividend of $0.2075 per …

Kenvue, Inc. Revenue Breakdown – FWB:J4D

Kenvue, Inc. (FWB:J4D) generated €12.88 billion in revenue last year, with its Self Care segment being the top performer, contributing €5.43 billion. The United States was the company's largest regional contributor, accounting for €5.50 billion in the same period. The report provides a financial …

Vulcan Materials Company (Holding Company) Revenue Breakdown – NYSE:VMC

Cenovus Energy (NYSE:CVE) Lowered to "Buy" Rating by Wall Street Zen

Wall Street Zen has downgraded Cenovus Energy (NYSE:CVE) from a "strong-buy" to a "buy" rating, despite the broader analyst community generally maintaining a favorable view of the stock. Other firms like RBC and Scotiabank have issued mixed-to-positive ratings. Cenovus Energy recently reported strong quarterly …

FDA Clears Kenvue's TYLENOL With Naproxen, First OTC Fixed-Dose Combination

(RTTNews) - Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) for pain relief. This new formulation combines the fast-acting relief of …

Vulcan Materials Co (VMC) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Vulcan Materials Co (VMC), detailing its current earnings forecast score, average price target from analysts, and peer comparison within the Construction Materials industry. It also includes anticipated revenue and EPS for upcoming quarters and a summary of …

Vulcan Materials Co (VMC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed timeline of historical dividend payouts for Vulcan Materials Co (VMC), including dividend amounts, record dates, payment dates, and ex-dividend dates. It also shows current stock information such as market cap and P/E ratio. The content indicates that Vulcan Materials …

EXP|Eagle Materials Inc|Price:213.650|Chg%:+6.540

Eagle Materials Inc. (EXP) shows stable fundamentals and significant growth potential, despite recent weak stock market performance. The company is considered fairly valued within the Construction Materials industry, ranking 4th out of 15. Analysts have a "Hold" rating with a target price of $226.38, …

Vulcan Materials Co (VMC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Vulcan Materials Co (VMC), detailing its financial performance by region. For the reported period, the company generated $7.93 billion (99.81%) in domestic revenue and $14.90 million (0.19%) from nondomestic sources. Information regarding business segment revenue and profit …

Cenovus Energy Inc. Revenue Breakdown – TSX:CVE

This article provides a detailed revenue breakdown for Cenovus Energy Inc (CVE) by business segment and region, presenting data in USD. For business segments, Crude Oil, Gasoline, and Diesel and Distillate are the largest contributors. Regionally, the United States and Canada account for the …

Envue Medical announces special shareholder meeting

Envue Medical will hold a virtual special shareholder meeting on August 14, 2026, to vote on a proposed reverse stock split, with a ratio between 1-for-2 to 1-for-50. Shareholders will also consider adjourning the meeting if more time is needed to solicit votes. This …

Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Kenvue Inc (KVUE) by business segment and geographical region. As of April 6, the company generated $2.87 billion from Face and Body Care and $2.42 billion from Other Self Care, with Northern America contributing the highest …

Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed historical overview of Kenvue Inc (KVUE) dividends and stock splits, including past and upcoming payout dates and amounts. It lists the dividend record dates, payment dates, and ex-dividend dates, detailing both interim and final cash dividends. The document also …

Cenovus Energy Inc. stock falls Friday, underperforms market

Cenovus Energy Inc. (CVE) saw its stock drop by 1.36% to C$41.30 on Friday, underperforming the broader Canadian market, which saw the S&P/TSX Composite Index rise by 0.50%. The company's stock closed 6.4% below its 52-week high of C$44.13, achieved on May 20th.